CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE8625.00114 (+1.34 %)
PREV CLOSE () 8511.00
OPEN PRICE () 8595.00
BID PRICE (QTY) 8606.85 (1)
OFFER PRICE (QTY) 8624.95 (2)
VOLUME 414
TODAY'S LOW / HIGH ()8535.00 8648.60
52 WK LOW / HIGH ()5000 9101
NSE8604.0089.5 (+1.05 %)
PREV CLOSE() 8514.50
OPEN PRICE () 8506.00
BID PRICE (QTY) 8607.50 (1)
OFFER PRICE (QTY) 8614.50 (1)
VOLUME 7224
TODAY'S LOW / HIGH() 8505.00 8650.00
52 WK LOW / HIGH ()4800.15 9167.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Shilpa Divekar Nirula - Chairman Sanjeev Kumar Panchal - Managing Director

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone : 080 6774 8000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE
NEWS
15Apr AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that AstraZeneca Pharma India had..
15Apr AstraZeneca Pharma surrenders marketin
AstraZeneca Pharma India has surrendered the marketing authorisation of..
05Apr AstraZeneca Pharma gets nod to import
AstraZeneca Pharma India has received permission from the Central Drugs..
28Mar AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that the company will be discontin..
06Mar AstraZeneca Pharma India gets nod to i
AstraZeneca Pharma India has received permission from the Central Drugs..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit308.51615.09
Gross Profit 420.2 2195.37
Operating Profit 849.72192.52
Net Sales 4402.912955.28
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 30931.70 (0.70%)
M.Cap ( in Cr)
65670.97
SMS Lifesciences (BSE)
 1446.00 (13.64%)
M.Cap ( in Cr)
432.33
Neuland Laboratories (BSE)
 12862.95 (0.95%)
M.Cap ( in Cr)
16453.88
TTK Healthcare (BSE)
 1325.00 (7.57%)
M.Cap ( in Cr)
1872.27
Ajanta Pharma (BSE)
 2695.00 (2.28%)
M.Cap ( in Cr)
33495.80
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 16.87%
MUTUAL FUNDS/UTI 5.04%
FI/BANKS/INSURANCE 0.13%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77110.3066.01 (0.09%)
NIFTY23421.95-15.25 (-0.07%)
Dow Jones 39669.39-699.57 (-1.73%)
Nasdaq 16307.16-516.01 (-3.07%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI